Article Versions Notes

Omole T, Pelayo E, Weinberg AS, Chalkias S, Endale Z, Tamms G, Sterling TM, Good L, Shekar T, Johnson M, et al. Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. Vaccines. 2025; 13(2):192. https://doi.org/10.3390/vaccines13020192

Omole, Tosin, Enrique Pelayo, Aaron S. Weinberg, Spyros Chalkias, Zelalem Endale, Gretchen Tamms, Tina M. Sterling, Lori Good, Tulin Shekar, Morgan Johnson, and et al. 2025. "Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age" Vaccines 13, no. 2: 192. https://doi.org/10.3390/vaccines13020192

Omole, T., Pelayo, E., Weinberg, A. S., Chalkias, S., Endale, Z., Tamms, G., Sterling, T. M., Good, L., Shekar, T., Johnson, M., Banniettis, N., Buchwald, U. K., & Esteves-Jaramillo, A. (2025). Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. Vaccines, 13(2), 192. https://doi.org/10.3390/vaccines13020192